drugset / Trial / NCT00723554

Iloprost Power Disc-15 in Pulmonary Arterial Hypertension

NCT00723554

Phase 3 Terminated 63 enrolled Actelion
Non-randomizedSingle-groupOpen-labelTreatment

Summary

A Phase IIIb, Multicenter, Open-Label Study of Patients With Pulmonary Arterial Hypertension Treated With Iloprost(Inhalation)Evaluating Safety and Inhalation Times When Converting From Power Disc-6 to Power Disc-15 With the I-neb® Adaptive Aerosol Delivery® System (I-neb® AAD®)

Timeline

Start
2008-07
Primary completion
2010-08
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Iloprost Other / unclassified Inhaled